Monoclonal/polyclonal antibodies and hybridoma/cell culture development and production services

QED Bioscience specializes in the development and provision of a wide range of antibodies, proteins, antigens, and related reagents aimed at supporting various research efforts, particularly in the fields of immunology and neuroscience. Their product offerings include custom antibody services, which encompass monoclonal and polyclonal antibody production, hybridoma development, and antibody purification. Additionally, QED provides specialized test kits and cell culture products, facilitating research in areas such as infectious diseases, cancer, and neurological disorders. Their commitment to innovation is evident in their continuous development of new antibody products and immunological services tailored to meet the evolving needs of their clients.

The company also emphasizes its focus on addressing significant health challenges, such as antibiotic resistance and neurodegenerative diseases like Alzheimer’s. QED's extensive catalog features antibodies targeting a variety of biological markers and pathways, including apoptosis, autophagy, and signal transduction, which are crucial for understanding complex biological processes. Their research tools are designed to aid scientists in their quest to uncover new therapeutic targets and develop effective treatments, thereby contributing to advancements in medical research and healthcare.

United States

QED Bioscience is a biotechnology company that specializes in designing and manufacturing antibodies, offering top-quality products and services to support clients in their research.

QED Bioscience

Company Details